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Effective use of self-monitoring of blood glucose (SMBG) 
requires that testing regimens are structured to identify 
meaningful patterns of glycemic control, data are presented 
in formats that facilitate identification of glycemic patterns 
and that users (health care providers and patients) accurately 
interpret and utilize the data to make appropriate decisions 
regarding therapy.1 Written logbooks are commonly used to 
record SMBG results and relevant information; however, uti-
lizing logbooks is often problematic for patients and their 
health care providers due to the high incidence of recording 
errors and/or information gaps and the complexity and 
volume of information presented.2 Only about 50% of adult 
SMBG logbooks can be considered accurate and reliable,3 
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Abstract
We assessed users’ proficiency and efficiency in identifying and interpreting self-monitored blood glucose (SMBG), insulin, 
and carbohydrate intake data using data management software reports compared with standard logbooks. This prospective, 
self-controlled, randomized study enrolled insulin-treated patients with diabetes (PWDs) (continuous subcutaneous insulin 
infusion [CSII] and multiple daily insulin injection [MDI] therapy), patient caregivers [CGVs]) and health care providers (HCPs) 
who were naïve to diabetes data management computer software. Six paired clinical cases (3 CSII, 3 MDI) and associated 
multiple-choice questions/answers were reviewed by diabetes specialists and presented to participants via a web portal in 
both software report (SR) and traditional logbook (TL) formats. Participant response time and accuracy were documented 
and assessed. Participants completed a preference questionnaire at study completion. All participants (54 PWDs, 24 CGVs, 
33 HCPs) completed the cases. Participants achieved greater accuracy (assessed by percentage of accurate answers) using 
the SR versus TL formats: PWDs, 80.3 (13.2)% versus 63.7 (15.0)%, P < .0001; CGVs, 84.6 (8.9)% versus 63.6 (14.4)%, P < 
.0001; HCPs, 89.5 (8.0)% versus 66.4 (12.3)%, P < .0001. Participants spent less time (minutes) with each case using the SR 
versus TL formats: PWDs, 8.6 (4.3) versus 19.9 (12.2), P < .0001; CGVs, 7.0 (3.5) versus 15.5 (11.8), P = .0005; HCPs, 6.7 
(2.9) versus 16.0 (12.0), P < .0001. The majority of participants preferred using the software reports versus logbook data. Use 
of the Accu-Chek Connect Online software reports enabled PWDs, CGVs, and HCPs, naïve to diabetes data management 
software, to identify and utilize key diabetes information with significantly greater accuracy and efficiency compared with 
traditional logbook information. Use of SRs was preferred over logbooks.
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and many patients frequently neglect to bring their logbooks 
to their clinic appointments,4 which speaks to the necessity 
to eliminate any potential burden for the patient and simplify 
data collection and transmission. However, even when log-
books data are meticulously maintained, patients may 
become overwhelmed or confused and unable to interpret 
and/or act upon their data.
During the past 10 years, several diabetes data manage-
ment software programs have become available, utilizing 
downloaded data from blood glucose meters, insulin pumps 
and continuous glucose monitoring (CGM) systems to pres-
ent information in a variety of statistical and graphical 
formats.
We hypothesized that the software report (SR) formats 
would enhance the ability of users who are inexperienced in 
the use of downloaded diabetes management data to accu-
rately and efficiently identify glucose patterns and other key 
information (eg, glucose statistics, insulin administration/
dosages, carbohydrate intake).
To test this hypothesis, we conducted a study, Accu-Chek 
Connect Reports Utility and Efficiency Study (ACCRUES), 
to assess the impact of utilizing online data management 
reports on users’ ability to accurately and efficiently interpret 
data and make appropriate treatment decisions. The evalua-
tion included patients with diabetes (PWDs) treated with 
multiple daily insulin injections (MDI) and continuous sub-
cutaneous insulin infusion (CSII), CGVs of pediatric MDI-
treated and CSII-treated patients and health care providers 
(HCPs) who were naïve to diabetes data management soft-
ware use.
Methods
This prospective, comparative, online survey enrolled PWDs 
treated with MDI and CSII therapy, CGVs of pediatric MDI-
treated and CSII-treated patients and HCPs who were not 
specialized in diabetes management. Participants were asked 
to review a series of clinical cases (based on actual patient 
data) and answer multiple-choice questions associated with 
each case. The cases were presented in both online SR and 
traditional logbook (TL) formats. The purpose of the study 
was to assess participants’ accuracy in answering each multi-
ple-choice question and the time required for their responses. 
Participants served as their own control.
Subjects
PWDs, CGVs, and HCPs from medical practices across the 
United States were recruited for the study. Medical special-
ties included family practitioner, internal medicine, and 
nurse practitioner.
Participants were identified through the existing physi-
cian database and recruited by contacting random samples of 
primary health care physicians and nurse practitioners (via 
email and/or fax), inviting them to call or email a market 
research firm (Qessential Medical Market Research, LLC 
[QMMR], Exeter, NH) to screen for the study. Email and fax 
invitations were sent to known diabetes specialists, request-
ing that they refer patients to call or email QMMR to screen 
for the study. The invitations included a patient/caregiver 
flyer, which the specialists could post in their offices.
PWD Eligibility. PWD eligibility criteria for the study included 
diagnosed type 1 or type 2 diabetes; treated with MDI or 
CSII therapy for ≥6 months; ≥18 years of age; makes major-
ity (>80%) of daily diabetes management decisions; per-
forms SMBG ≥3 times daily; has experience with keeping a 
standard logbook; adjusts prandial bolus insulin dosages; has 
access to a calculator; and possesses a computer with the 
capability to connect to the Internet. Patients were excluded 
from the study if they were a health care professional, rou-
tinely used continuous glucose monitoring (CGM), routinely 
used diabetes management software, or routinely down-
loaded their blood glucose meter or insulin pump data at 
home.
Caregiver (CGV) Eligibility. CGV eligibility criteria for the 
study included patient has diagnosed type 1 or type 2 diabe-
tes; patient has been treated with MDI or CSII therapy for 
≥6 months; CGV makes majority (>80%) of patient’s daily 
diabetes management decisions; measures patient’s blood 
glucose ≥3 times daily; keeps or helps patient review a 
standard logbook; adjusts prandial bolus insulin dosages 
for the patient; has access to a calculator; and possesses a 
computer with the capability to connect to the Internet. 
Patient caregivers were excluded from the study if they 
were a health care professional, had diabetes and treated 
with MDI or CSII therapy, the patient they care for rou-
tinely used continuous glucose monitoring (CGM), rou-
tinely used diabetes management software, or routinely 
downloaded their patients’ blood glucose meter or insulin 
pump data at home.
HCP Eligibility. Eligibility for the study required that HCPs 
are board certified in their specialty (internal medicine, 
family practice, or nurse practitioner), are actively in non-
academic patient care, have a diabetes population of ≥10%, 
manage diabetes patients with MDI or CSII, routinely 
examine blood glucose logbooks in their practice, recom-
mend blood glucose monitoring to their patients, and pos-
sesses a computer with the capability to connect to the 
Internet. HCPs were excluded from the study if they were 
recognized as diabetes specialists (eg, advanced training or 
certification in diabetes management), routinely used con-
tinuous glucose monitoring (CGM) in their practice, rou-
tinely used diabetes management software or downloaded 
blood glucose meter or insulin pump data in their practice, 
or had diabetes and treated with multiple daily insulin 
injection (MDI) or continuous subcutaneous insulin infu-
sion (CSII) therapy.
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Study Materials
Accu-Chek CONNECT Diabetes Management System. The 
Accu-Chek CONNECT Diabetes Management System 
(Roche Diagnostics, Indianapolis, Indiana, USA) is an 
investigational online tool that enables users of Accu-Chek 
blood glucose meters and insulin pumps (Roche Diagnos-
tics) to automatically download, visualize, and organize 
blood glucose, insulin delivery, carbohydrate intake, and 
other health-related data. For our assessments, screen shots 
of the various reports generated by the system were pre-
sented to participants via a web portal accessed from their 
computers (Figure 1).
Traditional Logbook Presentation. The comparator device was 
an electronic image of a completed Accu-Chek Logbook 
(Roche Diagnostics) (Figure 1).
Case Study Development
The primary investigator of the study developed 6 “master” 
cases with associated multiple-choice questions and 
responses. The cases were based on 2 weeks of SMBG data 
and other relevant diabetes management information from 
real patients with diabetes (3 MDI-treated, 3 CSII-treated). 
The cases were representative of various glycemic patterns 
and provided a broad example of clinical circumstances 
common to the management of type 1 and 2 diabetic 
patients on MDI and CSII therapy. Glycemic patterns 
included normal glycemia, hypoglycemia, preprandial 
hyperglycemia, postprandial hyperglycemia, and bedtime 
hyperglycemia.
From each master case, 2 “paired” cases” were developed 
(based on the same data) and formatted as an online SR case 
and corresponding TL case. Each case included a brief 
patient history, SMBG data, insulin dosage and administra-
tion, and CHO intake data (Figure 1).
The SRs were presented as screen shots of selected 
reports from the Accu-Chek Connect Diabetes Management 
System (6 reports for each report case); the same data were 
presented in the paired TL case as a screenshot of the log-
book (Figure 1). The multiple-choice questions, which were 
identical for each paired case, were organized into 3 catego-
ries: identification of meaningful diabetes information, 
identification of glycemic patterns, and appropriate diabetes 
management decisions.
The cases, multiple-choice questions, and responses were 
submitted to an expert panel, consisting of 2 physicians spe-
cialized in diabetes management and a certified diabetes edu-
cator for review. The cases, questions, and responses were 






Same questions asked  
2 cases from same        
2-wk SMBG data set 
10-12 questions per case 
Robert is a 62 year old male with type 2 diabetes. He has 
been wearing a pump for 6 years and is pleased with his 
current diabetes control. He just changed his insulin to 
Humalog from Novolog and wanted to share his SMBG data 
with his daughter and his doctor.  
Kathy is a 54 year old female with type 2 diabetes for 8 
years and has been wearing a pump for 2 years. She loves 
using an insulin pump to manage her diabetes because she 
travels a lot. She is pretty pleased with her overall diabetes 
control. She is seeing her doctor today for a routine visit. 
Figure 1. Presentation of paired cases.
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Outcome Measures
The primary outcome measures for the study were partici-
pants’ accuracy in answering the multiple choice questions 
for each case and the time required to provide their response. 
Accuracy and response time are presented as an aggregate of 
total questions for each case and by question category (eg, 
meaningful diabetes information, glycemic patterns, therapy 
decisions). A secondary measurement included a preference 
questionnaire which participants completed following case 
analyses. The investigator-developed questionnaire was 
designed to obtain participants’ feedback on their experience 
with the online reports versus standard logbook and per-
ceived value of the online reports.
Procedures
Potential participants completed a screening questionnaire to 
determine eligibility for the study. Requirements for web 
portal compatibility were assessed as part of screening. 
Eligible participants then received credentials to access the 
study web portal. The web portal was designed and tested for 
Internet Explorer 8 or newer, latest version of Firefox and 
Google Chrome on Windows 7 or newer operating systems, 
and Safari 5 or newer on Mac OS 10.6 or newer.
At the web portal, participants were asked to complete a 
demographic questionnaire, receive online orientation for 
both types of reports (online and logbook), perform an 
assessment of online and logbook cases, and complete a 
preference questionnaire. Four of the 6 cases (2 MDI-treated, 
2 CSII-treated) were selected and presented to HCPs. PWDs 
and CGVs received 3 paired cases relevant to their treatment 
group. Cases were presented in a manner that ensured paired 
cases would not be presented sequentially.
When each case was presented, the computer screen dis-
played 1 question at a time. The time needed for answering a 
question during the case studies was measured and docu-
mented. Participants were prevented from moving on to the 
next question until the current question had been answered. 
Participants were unable to return to previous questions to 
edit their answer. The HCP/patient/caregiver information 
sheets that participants reviewed did not disclose that the dif-
ference between methods in speed (time to review each case) 
would be calculated. The information sheets did disclose that 
breaks between cases would be allowed.
Participants were required to complete the demographic 
questionnaire and cases and preference questionnaire within 
7 days of receiving their login credentials.
Statistical Analysis
The primary analysis objective is to compare the accuracy 
and speed of obtaining meaningful diabetes information, 
identifying important glycemic patterns, and making appro-
priate therapy decisions utilizing data from SR and TL case 
presentations. Questions were categorized as correct or 
incorrect based on the expert panel agreement. Accuracy per 
participant was calculated as the percentage of questions 
over all cases with a correct response. Speed was calculated 
as the sum of the time spent answering the questions. The 
time spent answering the question was determined by the 
web-based application as the number of seconds from the 
time when the participant first enters the page to the time 
when the participant clicks “go to next page.”
For each participant, differences in accuracy and speed were 
calculated as the SR value minus the TL value. Descriptive sta-
tistics (mean, standard deviation, median, minimum, and maxi-
mum) are presented for the difference between methods in 
accuracy and speed for the questions. The statistical signifi-
cance of the difference in methods was tested using paired t 
tests. The participant needed to answer the same question 
within each case pair for that question to be included in calcula-
tions of accuracy and speed for that participant. All analyses 
include the evaluable population of participants, defined as 
those participants who completed at least 1 evaluable case 
(>50% of the questions for each paired case are answered).
Information from the demographic questionnaires is sum-
marized for the study group. Continuous variables are sum-
marized by descriptive statistics (mean, standard deviation, 
median, minimum, and maximum). Categorical variables are 
summarized by the number and percentage of participants 
within each category.
Table 1. Demographic Characteristics of Study Patient/Caregiver Participants.
Characteristic MDI PWD (n = 27) CSII PWD (n = 27) P value MDI CGV (n = 13) CSII CGV (n = 11) P value
Age, years (SD) 51.7 (11.9) 41.0 (16.5) .009 45.9 (6.2) 46.0 (7.2) .96
Gender, female n (%) 19 (70.4)) 20 (74.1) .76 10 (76.9) 10 (90.9) .36
Type 1 diabetes, n (%) 19 (70.4) 25 (92.6) .36 13 (100.0)a (PWD) 11 (100.0)a (PWD) .92
Diabetes duration, years (SD) 26.8 (10.6) 21.1 (14.1) .10 4.77 (4.4) 6.1 (4.44) .47
Last HbA1c, % (SD) 7.67 (1.7) 7.46 (1.0) .57 8.03 (1.0) 8.01 (1.0) .96
Uses CHO counting to adjust meal 
insulin dose, n (%)
21 (77.8) 27 (100.0) .009 13 (100.0) 11 (100.0) —
SMBG frequency per day, n (SD) 3.74 (0.7) 4.22 (0.6) .009 4.3 (0.6) 4.4 (0.5) .52
aRelevant to caregiver patient.
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The preference questionnaires are summarized for the 
study group. Numbers and percentages of participants within 
each numerical level of the Likert-type scale are presented 
for each question. Two-sided P values are reported; P values 
less than or equal to .05 are considered statistically signifi-
cant. There was no imputation for missing data. The analyses 
were performed using SAS version 9.2 or higher.
Results
A total of 54 PWDs (n = 27 MDI-treated, n = 27 CSII-treated), 
24 CCVs (n = 13 MDI, n = 11 CSII), and 33 HCPs (n = 18 
family practitioner; n = 12 internal medicine; n = 3 nurse 
practitioner) were enrolled in the study. All participants were 
included in the evaluable population analyses. Demographic 
characteristics of the participants are presented in Table 1 
(PWDs/CGVs) and Table 2 (HCPs). Differences in age, type 
of diabetes, use of CHO counting, and SMBG frequency were 
seen between the PWD study groups; no between-group dif-
ferences were seen among the CGV study groups.
PWD Performance
Accuracy. PWDs showed greater overall accuracy, assessed 
by mean (SD) percentage of accurate responses, using SR 
presentations compared with TL data (80.3 [13.2]% vs 63.7 
[15.0]%, P < .0001) with no difference in improvement 
between the patient groups (P = .6522). In both groups, accu-
racy of SR compared with TL use was greater when answer-
ing questions related to diabetes information and glycemic 
patterns but not therapy decisions (Figures 2A and 2B). 
MDI-treated PWDs showed no change in accuracy related to 
therapy decision questions using the SR presentations versus 
TL data, whereas CSI-treated PWDs showed less accuracy 
using the SR presentations.
Time Required. PWDs spent less time (average minutes per 
case) reviewing data and answering questions using SR pre-
sentations compared with TL data (8.6 [4.3] vs 19.9 [12.2] 
minutes, P < .0001) (Figures 2C and 2D). The mean (SD) 
reduction in time for all cases was greater using the SR pre-
sentations among CSII-treated PWDs compared with MDI-
treated PDWs (–43.2 [37.5] minutes vs –24.6 [30.2] minutes) 
but this difference did not reach statistical significance (P = 
.0509). In both groups, less time was spent when answering 
questions related to diabetes information and glycemic pat-
terns but not therapy decisions.
CGV Performance
Accuracy. CGVs showed greater overall accuracy using SR 
presentations compared with TL data (84.6 [8.9]% vs 63.6 
[14.4]%, P < .0001) with no between-group difference in 
improvement (P = .9116). In both groups, accuracy was 
greater when answering questions related to diabetes 
information and glycemic patterns but not therapy decisions 
(Figures 3A and 3B).
Table 2. Demographic Characteristics of HCPs.
Characteristic All HCPs (n = 33)
Age, years (SD) 51.3 (8.7)
Gender, n(%)
 Male 21 (63.6)
 Female 12 (36.4)
Time since graduated from medical school/
APRN training, years (SD)
24.1 (8.9)
Type of practice, n (%)
 Solo 8 (24.2)
 Private/multiphysician 15 (45.5)
 Hospital owned 10 (30.3)
 Other 1 (3.0)
Percentage of patients with type 1 diabetes
 <5% 25 (75.8)
 5-10% 5 (15.2)
 10-15% 3 (9.1)
Percentage of patients with type 2 diabetes
 <10% 1/ (3.0)
 10-20% 11 (33.3)
 20-30% 11 (33.3)
 30-40% 5 (15.2)
 40-50% 1 (3.0)
 >50% 4 (12.1)
Percentage of patients on MDI therapy
 <10% 12 (36)
 10-25% 14 (42.4)
 25-50% 6 (18.2)
 50-75% 1 (3.0)
Percentage of patients on CSII therapy
 <10% 32 (97)
 10-25% 1 (3.0)
Average HbA1c of diabetes patients, n (%)
 <7% 5 (15.2)
 7-8% 23 (69.7)
 >8% 1 (3.0)
 Do not know 4 (12.1)
Communicate with diabetes patients outside of office visits, n (%)
 No 5 (15.2)
 Yes 28 (84.8)
Receive compensation for these interactions, n (%)
 No 25 (89.3)
 Yes 3 (10.7)
Review SMBG data
 No 0 (0.0)
 Yes 33 (100.0)
Routinely seek additional training/knowledge in diabetes, n (%)
 No 4 (12.1)
 Yes 29 (87.9)
Ever unable to prescribe appropriate therapy due to lack of insurance 
coverage or inability to prior authorize, n (%)
 No 2 (6.1)
 Yes 31 (93.9)
Occurrence of inability to prescribe appropriate therapy, n (%)
 <10% 9 (29)
 10-25% 17 (54.8)
 25-50% 3 (9.7)
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Figure 2. PWD accuracy (A/B) and efficiency (C/D) of using software report (SR) formats compared with traditional logbook (TL) data: 
MDI-treated PWDs and CSII-treated PWDs.
Figure 3. CGV accuracy (A/B) and efficiency (C/D) of using software report (SR) formats compared with traditional logbook (TL) data: 
MDI CGVs and CSII CGVs.
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Figure 4. HCP accuracy (A) and efficiency (B) of using software report (SR) formats compared with traditional logbook (TL) data.
Time Required. CGVs spent less time (average minutes per 
case) reviewing data and answering questions using SR pre-
sentations compared with TL data (7.0 [3.5] vs 15.5 [11.8] 
minutes, P = .0005) (Figures 3C and 3D). The mean (SD) 
reduction in time for all cases was greater using the SR pre-
sentations among CSII CGVs compared with MDI CGVs 
(-33.8 [34.0] vs –18.3 [27.0] minutes) but did not reach sta-
tistical significance (P = .2264). In both groups, less time 
was spent when answering questions related to diabetes 
information and glycemic patterns but not therapy 
decisions.
HCP Performance
Accuracy. HCPs showed greater accuracy, overall, using SR 
presentations compared with TL data: 89.5 (8.0)% versus 
66.4 (12.3)%, P < .0001. Accuracy was greater when 
answering questions related to diabetes information and gly-
cemic patterns but not therapy decisions (Figure 4A).
Time Required. HCPs spent less time (average minutes per 
case) reviewing data and answering questions using SR 
presentations compared with TL data: 6.7 (2.9) versus 16.0 
(12.0), P < .0001. Less time was spent when answering 
questions related to diabetes information and glycemic 
patterns but not therapy decisions (Figure 4B).
Format Preferences
PWD and CGV Preferences. Most PWDs agreed (11.1%) or 
strongly agreed (77.8%) that they preferred using the SR 
formats versus TL data, and more than half agreed (24.1%) 
or strongly agreed (33.3%) that they would more likely 
perform SMBG per clinician recommendations when using 
the SR reports. A large majority of CGVs agreed (26.1%) 
or strongly agreed (69.6%) that they preferred using the 
SR repots. Figures 5A and 5B present PWD and CGV 
response rates to questions relating to their perceptions of 
SR use.
HCP Preferences
All HCPs agreed (24.2%) or strongly agreed (75.8%) that they 
preferred using the SR formats versus TL data. Figure 5C 
presents HCP response rates to questions relating to the clini-
cal utility and potential efficiency associated with SR use.
Discussion
In this prospective, comparative, online survey, participants 
demonstrated greater accuracy and time efficiency using the 
online reports compared with TL data. The majority of partici-
pants also expressed a strong preference to using the reports.
A major strength of the study is that participants were 
naïve to use of diabetes data management software, which 
suggests that effective use of the online reports is highly fea-
sible in real-world situations. This is significant for both 
PWDs and CGVs, who are burdened by the many tasks asso-
ciated with daily diabetes management and who are often 
overwhelmed by the data they generate. It is also an impor-
tant finding for health care providers in primary care set-
tings. Although these HCPs often have little experience 
managing diabetes, they provide care for the vast majority of 
individuals with diabetes in the United States who receive 
treatment for their disease.5
It was surprising to see that so many PWDs and CGVs in 
our study performed at close to the level seen in the HCPs. 
This reflects well on the utility of the SRs and, hopefully, 
demonstrates to HCPs that PWDs and CGVs are able to 
effectively interpret and utilize the vast amounts of data 
generated through daily diabetes management when pro-
vided the tools to do so. Nevertheless, the relatively low 
accuracy rates among all study participants underscore the 
need to provide additional training to clinicians and patients 
and/or the need for software that enhances decision 
making.
A key strength of our study was use of both quantitative 
and qualitative measures. Through this design, we were able 
to link participants’ strong preferences for using the reports 
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Strongly Agree  Agree Neutral Disagree Strongly Disagree
Figure 5. Participant perceptions of software report (SR) value and utility.
with empirical measurement of participants’ performance in 
both accuracy of and efficiency, which supports the validity 
of our findings.
Several limitations of the study are noteworthy. First, to 
ensure that participants had equivalent data in the online 
reports and the logbooks, the information presented in the 
logbooks was more complete and more legible than what is 
typically available. This suggests that the benefits associ-
ated with the online reports may be understated compared to 
what would typically be found in real-world situations. 
Although it could be argued that the more extensive infor-
mation provided in the logbook would presumably require 
more time to review and analyze, it is important to note that 
this “optimized” information is required for appropriate 
decision making.
A second limitation relates to the “therapy decision” ques-
tions and how they were presented to participants. As reported, 
we saw no differences in participants’ accuracy and speed in 
answering these questions; however, we suspect that the lim-
ited number of questions relating to therapy decisions resulted 
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in a lack of sensitivity to detect differences in accuracy and 
efficiency. During the expert panel review, diabetes manage-
ment decision questions that the panel felt tested the partici-
pants’ personal diabetes knowledge instead of use of the system 
to make appropriate diabetes management decisions were 
eliminated. This resulted in a limited number of questions. It is 
also likely that the questions may have directed participants’ 
attention to the “correct” glycemic abnormalities, which they 
may have missed when identifying glycemic patterns earlier in 
the survey. In real-world situations, PWDs, CGVs, or HCPs 
would not be directed to these glycemic abnormalities; there-
fore, inaccuracies in management decisions likely would be 
more pronounced. In hindsight, we believe that utilizing sepa-
rate patient cases for questions regarding therapy decisions 
would have addressed this problem.
Although our findings clearly demonstrate that use of 
online reports facilitate greater accuracy and efficiency in 
analyzing and acting upon patient diabetes management 
data, the time-consuming and cumbersome procedure for 
uploading stored meter data into a computer to generate cus-
tomized reports remains an obstacle for health care provid-
ers. The availability of tools such as the Accu-Chek 
CONNECT Diabetes Management System could provide a 
solution. The software will eventually be available as a 
standalone program and, in the future, as a component of an 
integrated system, pending regulatory approval. The system 
would automatically upload blood glucose meter to a smart 
phone application. The data would automatically be sent to a 
“cloud” storage platform, which could be accessed by diabe-
tes patients/caregivers and their health care providers.
Conclusions
Technology advancements that provide seamless and wire-
less patient data in a format that facilitates accurate and effi-
cient identification of glucose patterns will likely enhance 
the ability of patients, caregivers and health care profession-
als to utilize the data in meaningful ways. In the environ-
ment of increasing diabetes prevalence and decreasing 
reimbursement (with associated constraints on health care 
providers’ time), a solution that reduces diabetes burden, 
facilitates efficiency, and improves quality of care is a posi-
tive addition to existing armamentarium of diabetes man-
agement tools.
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